HighTower Advisors’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
Other funds holding EXAS
PRS
PWMAG
IA
HNB
BC
HighTower Advisors's EXAS Position: Q1 2026 in Review
HighTower Advisors sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 1,227,761 shares — an estimated $125M sold.
HighTower Advisors first reported a position in EXAS in Q2 2013 and held it in 51 quarters. The position peaked at $125M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.
- HighTower Advisors reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
- HighTower Advisors sold 1,227,761 Exact Sciences shares in Q1 2026, an estimated $125M.
- HighTower Advisors first reported a position in Exact Sciences in Q2 2013 and held it in 51 quarters.
- HighTower Advisors's Exact Sciences position peaked at $125M in Q4 2025.
- 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.
Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.